| Primary |
| Product Used For Unknown Indication |
40.0% |
| Pain |
19.4% |
| Drug Use For Unknown Indication |
9.4% |
| Back Pain |
6.7% |
| Colorectal Cancer |
3.9% |
| Type 2 Diabetes Mellitus |
3.3% |
| Procedural Pain |
2.8% |
| Hepatitis C |
2.2% |
| Endometrial Cancer |
1.7% |
| Headache |
1.7% |
| Anaesthesia |
1.1% |
| Dependence |
1.1% |
| Migraine |
1.1% |
| Neoplasm Malignant |
1.1% |
| Sedative Therapy |
1.1% |
| Shoulder Pain |
1.1% |
| Abdominal Pain |
0.6% |
| Anxiety |
0.6% |
| Arthritis |
0.6% |
| Depression |
0.6% |
|
| Medication Error |
15.0% |
| Nausea |
7.5% |
| Product Quality Issue |
7.5% |
| Drug Dispensing Error |
5.0% |
| Overdose |
5.0% |
| Product Formulation Issue |
5.0% |
| Product Substitution Issue |
5.0% |
| Pruritus |
5.0% |
| Renal Failure Acute |
5.0% |
| Serotonin Syndrome |
5.0% |
| Tremor |
5.0% |
| Vision Blurred |
5.0% |
| Visual Disturbance |
5.0% |
| Vomiting |
5.0% |
| Anxiety |
2.5% |
| Cerebrovascular Accident |
2.5% |
| Constipation |
2.5% |
| Convulsion |
2.5% |
| Death |
2.5% |
| Dehydration |
2.5% |
|
| Secondary |
| Pain |
24.3% |
| Product Used For Unknown Indication |
23.3% |
| Back Pain |
11.9% |
| Drug Use For Unknown Indication |
6.0% |
| Type 2 Diabetes Mellitus |
4.3% |
| Depression |
3.5% |
| Anxiety |
3.3% |
| Fibromyalgia |
2.7% |
| Bipolar Disorder |
2.3% |
| Neuralgia |
2.3% |
| Analgesic Effect |
2.1% |
| Pain In Extremity |
2.0% |
| Panic Attack |
2.0% |
| Neuropathy Peripheral |
1.8% |
| Neck Pain |
1.6% |
| Arthralgia |
1.5% |
| Drug Abuse |
1.5% |
| Breakthrough Pain |
1.3% |
| Headache |
1.2% |
| Carpal Tunnel Syndrome |
1.1% |
|
| Pain |
11.7% |
| Visual Disturbance |
11.7% |
| Drug Hypersensitivity |
6.5% |
| Drug Ineffective |
6.5% |
| Urticaria |
5.8% |
| Vision Blurred |
5.8% |
| Spinal Disorder |
5.2% |
| Feeling Abnormal |
3.9% |
| Overdose |
3.9% |
| Renal Failure Acute |
3.9% |
| Treatment Noncompliance |
3.9% |
| Urinary Tract Infection |
3.9% |
| Visual Impairment |
3.9% |
| Weight Increased |
3.9% |
| Constipation |
3.2% |
| Death |
3.2% |
| Drug Withdrawal Syndrome |
3.2% |
| Nausea |
3.2% |
| Respiratory Depression |
3.2% |
| Somnolence |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.1% |
| Pain |
18.3% |
| Drug Use For Unknown Indication |
8.7% |
| Depression |
4.1% |
| Hypertension |
3.7% |
| Rheumatoid Arthritis |
3.3% |
| Back Pain |
3.3% |
| Anxiety |
3.3% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Multiple Sclerosis |
2.4% |
| Fibromyalgia |
2.3% |
| Nausea |
2.2% |
| Crohn's Disease |
2.0% |
| Hepatitis C |
2.0% |
| Insomnia |
1.9% |
| Diabetes Mellitus |
1.7% |
| Osteoporosis |
1.7% |
| Muscle Spasms |
1.6% |
| Sleep Disorder |
1.5% |
| Blood Cholesterol Increased |
1.5% |
|
| Vomiting |
14.0% |
| Pulmonary Embolism |
8.2% |
| Weight Decreased |
7.8% |
| Drug Ineffective |
6.9% |
| Pain |
6.9% |
| Wrong Technique In Drug Usage Process |
6.8% |
| Weight Increased |
6.7% |
| Urinary Tract Infection |
5.0% |
| Pneumonia |
4.9% |
| Nausea |
3.8% |
| Death |
3.5% |
| Pain In Extremity |
3.2% |
| Tremor |
3.2% |
| Somnolence |
3.0% |
| Deep Vein Thrombosis |
2.9% |
| Headache |
2.7% |
| Oedema Peripheral |
2.6% |
| Rash |
2.6% |
| Vision Blurred |
2.6% |
| Withdrawal Syndrome |
2.6% |
|
| Interacting |
| Pain |
23.9% |
| Herpes Zoster |
10.9% |
| Smoking Cessation Therapy |
9.8% |
| Depression |
5.4% |
| Narcolepsy |
5.4% |
| Neck Pain |
5.4% |
| Swelling |
5.4% |
| Constipation |
4.3% |
| Fibromyalgia |
4.3% |
| Myofascial Pain Syndrome |
4.3% |
| Tobacco Abuse |
4.3% |
| Bladder Disorder |
3.3% |
| Hypertension |
2.2% |
| Insomnia |
2.2% |
| Product Used For Unknown Indication |
2.2% |
| Viral Infection |
2.2% |
| Anxiety |
1.1% |
| Arthralgia |
1.1% |
| Cardiac Disorder |
1.1% |
| Drug Use For Unknown Indication |
1.1% |
|
| Pain |
23.1% |
| Narcolepsy |
11.5% |
| Off Label Use |
7.7% |
| Somnambulism |
7.7% |
| Throat Tightness |
7.7% |
| Urinary Incontinence |
7.7% |
| Vision Blurred |
7.7% |
| White Blood Cell Count Increased |
7.7% |
| Drug Ineffective |
3.8% |
| Drug Interaction |
3.8% |
| Insomnia |
3.8% |
| Therapeutic Response Decreased |
3.8% |
| Urinary Hesitation |
3.8% |
|
